Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study. (Q54565078)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study. |
scientific article |
Statements
Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study. (English)
1 reference
A Kotsakis
1 reference
E-K Vetsika
1 reference
S Christou
1 reference
D Hatzidaki
1 reference
N Vardakis
1 reference
D Aggouraki
1 reference
G Konsolakis
1 reference
V Georgoulias
1 reference
Ch Christophyllakis
1 reference
P Cordopatis
1 reference
K Kosmatopoulos
1 reference
D Mavroudis
1 reference
25 August 2011
1 reference
23
1 reference
442-449
1 reference
2
1 reference
Identifiers
1 reference